If you have been reading about anti-doping and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-27. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
2C-B tablets often contain a dose of 5 or 10 mg of the drug. Low doses of 2C-B like 5 to 10 mg orally are said to produce stimulation, entactogen-like effects, and perceptual enhancement, while higher doses like 10 to 20 mg orally are said to produce psychedelic and hallucinogenic effects. 2C-B is frequently used at low doses as a substitute for MDMA. It is often used by people who go to electronic music festivals, also known as raves. The drug is also frequently used at clubs and parties, at home, or in nature. 2C-B is often combined with other drugs, such as MDMA, alcohol, and cannabis. Besides recreational use, 2C-B has been used in psychedelic-assisted psychotherapy at doses of 15 to 30 mg orally.
linking to primary rather than secondary sources and prioritizing stable sites avoiding links that point to resources on researchers' personal pages using clean URLs or otherwise employing URL normalization or URL canonicalization using permalinks and persistent identifiers such as ARKs, DOIs, Handle System references, PURLs, or content addressing avoiding linking to documents other than web pages avoiding deep linking linking to web archives such as the Internet Archive, WebCite, archive.today, Perma.cc, Amber, or Arweave Strategies pertaining to the protection of existing links include:
In fact, different organs in the body - even between different species - are known to utilize a similar sets of paracrine factors in differential development. The highly conserved receptors and pathways can be organized into four major families based on similar structures: fibroblast growth factor (FGF) family, Hedgehog family, Wnt family, and TGF-β superfamily. Binding of a paracrine factor to its respective receptor initiates signal transduction cascades, eliciting different responses.
During the fourth century, Aquileia maintained its importance. Constantine sojourned there on numerous occasions. It became a naval station and the seat of the Corrector Venetiarum et Histriae. A mint was established, of which the coins were very numerous. The bishop of the Diocese of Aquileia obtained the rank of metropolitan archbishop. A council held in the city in 381 was only the first of a series of Councils of Aquileia that have been convened over the centuries. However, the city played a part in the struggles between the rulers of the fourth century. In 340, the emperor Constantine II was killed nearby while invading the territory of his younger brother Constans.
Sources: en.wikipedia.org
The Gallery of Palaeontology and Comparative Anatomy was built between 1894 and 1897 by architect Ferdinand Dutert, who had built the innovative iron-framed Galerie des machines at the 1889 Paris Exposition. A new pavilion in the same style was added to the west side of the gallery; it was completed in 1961. In front of the Gallery is the Iris Garden, created in 1964, which displays 260 varieties of iris flowers, and a sculpture, "Nymph with a pitcher" (1837) by Isidore Hippolyte Brion. The sides of gallery are also decorated with sculpture; twelve relief sculptures of animals in bronze and fourteen medallions of famous biologists. The ironwork grill and stone arches over the entrance are filled with elaborate designs and sculpture of seashells. Inside the entrance is a large marble statue of an Orangutan strangling a hunter, created in 1885 by the noted animal sculptor Emmanuel Fremiet, best known for his statue of Joan of Arc on horseback on the Place des Pyramides in Paris.
Naturally occurring tungsten (74W) consists of five isotopes. Four are considered stable (182W, 183W, 184W, and 186W) and one is slightly radioactive, 180W, with an extremely long half-life of (1.59±0.05)×1018 years. This results in about two alpha decays of 180W per gram of natural tungsten per year, so for most practical purposes, 180W can be considered stable. The other naturally occurring isotopes are also capable of alpha decay and so only observationally stable. Artificial radioisotopes of tungsten have been observed from 156W to 197W, the most stable of which are 181W with a half-life of 120.96 days, 185W with a half-life of 75.1 days, 188W with a half-life of 69.77 days and 178W with a half-life of 21.6 days. All of the remaining radioactive isotopes have half-lives less than one day, and most of these less than 8 minutes. The most stable known meta state is 179m1W with half-life 6.40 minutes.
Is it morally right to tamper with nature? Is one playing God when creating new life? What happens if a synthetic organism accidentally escapes? What if an individual misuses synthetic biology and creates a harmful entity (e.g., a biological weapon)? Who will have control of and access to the products of synthetic biology? Who will gain from these innovations? Investors? Medical patients? Industrial farmers? Does the patent system allow patents on living organisms? What about parts of organisms, like HIV resistance genes in humans? What if a new creation is deserving of moral or legal status? The ethical aspects of synthetic biology has three main features: biosafety, biosecurity, and the creation of new life forms. Other ethical issues mentioned include the regulation of new creations, patent management of new creations, benefit distribution, and research integrity. Ethical issues have surfaced for recombinant DNA and genetically modified organism (GMO) technologies and extensive regulations of genetic engineering and pathogen research were in place in many jurisdictions. Amy Gutmann, former head of the Presidential Bioethics Commission, argued that we should avoid the temptation to over-regulate synthetic biology in general, and genetic engineering in particular. According to Gutmann, "Regulatory parsimony is especially important in emerging technologies...where the temptation to stifle innovation on the basis of uncertainty and fear of the unknown is particularly great.
Sources: en.wikipedia.org
=== Early works and origins === The Fisher King first appears in Chrétien de Troyes's Perceval, the Story of the Grail in the late 12th century, but the character's roots may lie in Welsh mythology. He may be derived from the figure of Brân the Blessed in the Mabinogion. In the Second Branch of the Mabinogi, Bran has a cauldron that can resurrect the dead, albeit imperfectly: the revived dead can no longer speak. He gives this cauldron to the king of Ireland as a wedding gift for him and Bran's sister Branwen. Later, Bran wages war on the Irish and is wounded in the foot or leg, and the cauldron is destroyed. He asks his followers to sever his head and take it back to Britain, and his head continues talking and keeps them company on their trip. The group lands on the island of Gwales, where they spend 80 years in a castle of joy and abundance, but eventually they leave and bury Bran's head in London. This story has analogues in two other important Welsh texts: the Mabinogion tale "Culhwch and Olwen", in which King Arthur's men must travel to Ireland to retrieve a magical cauldron, and the poem The Spoils of Annwn, which speaks of a similar mystical cauldron sought by Arthur in the otherworldly land of Annwn.
The UK Independence Party, which had 500 council seats in 2014, loses the remainder of its councillors. Members of the RMT vote to renew the union's mandate to take strike action for a further six months. 5 May – Following the first conviction for trafficking for the purposes of organ removal in England and Wales, Nigerian senator Ike Ekweremadu is sentenced to nine years and eight months in prison after bringing a young street trader to the UK in order to procure his kidney for a transplant. The senator's wife and a doctor who also assisted in the plan are also sent to prison. 6 May Coronation of Charles III and Camilla: The Coronation takes place at Westminster Abbey, London, with the two-hour ceremony emphasising diversity and inclusion. There are contributions from several faiths, including Muslim, Jewish, Hindu, Buddhist and Sikh representatives, while elements of the ceremony are also held in the Welsh and Gaelic languages. Graham Smith, leader of the Republic pressure group, is arrested at a protest in Trafalgar Square prior to the coronation. 7 May Coronation of Charles III and Camilla: Coronation Big Lunch events take place across the country along with street parties in various locations. The Coronation Concert takes place at Windsor Castle. Officials at Westminster City Council say they are "deeply concerned" at the arrest of three women's safety volunteers hours before the Coronation. In response the Metropolitan Police says it "received intelligence" people "were planning to use rape alarms to disrupt the procession".
=== Pair-wise epitope mapping === As SPR allows real-time monitoring, individual steps in sequential binding events can be thoroughly assessed when investigating the suitability between antibodies in a sandwich configuration. Additionally, it allows the mapping of epitopes as antibodies of overlapping epitopes will be associated with an attenuated signal compared to those capable of interacting simultaneously.
==== Hawaii ==== In Hawaii, where cuisine is heavily influenced by Asian cultures, glass noodles are known locally as long rice, supposedly because the process of making the noodles involves extruding the starch through a potato ricer. They are used most often in chicken long rice, a dish of glass noodles in chicken broth that is often served at luaus.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.